These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19533094)

  • 21. The risk associated with hyperoncotic colloids in patients with shock.
    Schortgen F; Girou E; Deye N; Brochard L;
    Intensive Care Med; 2008 Dec; 34(12):2157-68. PubMed ID: 18685828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order?
    Honore PM; Joannes-Boyau O; Boer W
    Intensive Care Med; 2008 Dec; 34(12):2127-9. PubMed ID: 18685827
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
    Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
    Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients.
    Boldt J; Brosch Ch; Röhm K; Papsdorf M; Mengistu A
    Br J Anaesth; 2008 Apr; 100(4):457-64. PubMed ID: 18305082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation.
    Blasco V; Leone M; Antonini F; Geissler A; Albanèse J; Martin C
    Br J Anaesth; 2008 Apr; 100(4):504-8. PubMed ID: 18256055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colloid solutions for fluid resuscitation.
    Bunn F; Trivedi D; Ashraf S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD001319. PubMed ID: 18253989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis.
    Wiedermann CJ
    BMC Emerg Med; 2008 Jan; 8():1. PubMed ID: 18218122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
    Brunkhorst FM; Engel C; Bloos F; Meier-Hellmann A; Ragaller M; Weiler N; Moerer O; Gruendling M; Oppert M; Grond S; Olthoff D; Jaschinski U; John S; Rossaint R; Welte T; Schaefer M; Kern P; Kuhnt E; Kiehntopf M; Hartog C; Natanson C; Loeffler M; Reinhart K;
    N Engl J Med; 2008 Jan; 358(2):125-39. PubMed ID: 18184958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colloids versus crystalloids for fluid resuscitation in critically ill patients.
    Perel P; Roberts I
    Cochrane Database Syst Rev; 2007 Oct; (4):CD000567. PubMed ID: 17943746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin.
    Boldt J; Brosch C; Ducke M; Papsdorf M; Lehmann A
    Crit Care Med; 2007 Dec; 35(12):2740-6. PubMed ID: 17893629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly.
    Lehmann GB; Asskali F; Boll M; Burmeister MA; Marx G; Hilgers R; Förster H
    Br J Anaesth; 2007 May; 98(5):635-44. PubMed ID: 17456491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hydroxyethyl starch administration on renal function in critically ill patients.
    Sakr Y; Payen D; Reinhart K; Sipmann FS; Zavala E; Bewley J; Marx G; Vincent JL
    Br J Anaesth; 2007 Feb; 98(2):216-24. PubMed ID: 17251213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?
    Mills GH
    Br J Anaesth; 2007 Feb; 98(2):157-9. PubMed ID: 17251208
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluid resuscitation and the septic kidney.
    Bagshaw SM; Bellomo R
    Curr Opin Crit Care; 2006 Dec; 12(6):527-30. PubMed ID: 17077681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal impact of fluid management with colloids: a comparative review.
    Davidson IJ
    Eur J Anaesthesiol; 2006 Sep; 23(9):721-38. PubMed ID: 16723059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of hydroxyethyl starch.
    Jungheinrich C; Neff TA
    Clin Pharmacokinet; 2005; 44(7):681-99. PubMed ID: 15966753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferred plasma volume expanders for critically ill patients: results of an international survey.
    Schortgen F; Deye N; Brochard L;
    Intensive Care Med; 2004 Dec; 30(12):2222-9. PubMed ID: 15452693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind study.
    Jungheinrich C; Sauermann W; Bepperling F; Vogt NH
    Drugs R D; 2004; 5(1):1-9. PubMed ID: 14725484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery.
    Winkelmayer WC; Glynn RJ; Levin R; Avorn J
    Kidney Int; 2003 Sep; 64(3):1046-9. PubMed ID: 12911555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers.
    Waitzinger J; Bepperling F; Pabst G; Opitz J
    Drugs R D; 2003; 4(3):149-57. PubMed ID: 12757400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.